Suppr超能文献

纳武单抗诱导治疗转移性肾细胞癌患者后的远隔效应——原发标本的独特病理特征:一例报告

Abscopal effect following nivolumab induction in a patient with metastatic renal cell carcinoma-unique pathological features of the primary specimen: A case report.

作者信息

Hori Kanta, Hirohashi Yoshihiko, Aoyagi Toshiki, Taniguchi Narumi, Murakumo Masashi, Miyata Haruka, Torigoe Toshihiko, Abe Takashige, Shinohara Nobuo, Morita Ken

机构信息

Department of Urology, Kushiro City General Hospital, Kushiro 085-0822, Japan.

Department of Pathology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.

出版信息

Exp Ther Med. 2020 Mar;19(3):1903-1907. doi: 10.3892/etm.2020.8423. Epub 2020 Jan 3.

Abstract

The case of a patient with metastatic renal cell carcinoma who exhibited the abscopal effect following treatment by anti-programmed death-1 (PD-1) antibody is presented. A 40-year-old woman was diagnosed with an 8.2-cm renal tumor without distant metastases, and radical nephrectomy was subsequently performed. Pathological examination revealed a clear cell renal cell carcinoma. At 3 months after surgery, the patient developed one lung metastasis. Following treatment with interferon and three types of tyrosine kinase inhibitors, anti-PD1 antibody (nivolumab) was started. During the treatment, para-aortic/supraclavicular lymph nodes and several lung lesions remained, although other lesions decreased markedly. The patient was subsequently treated by palliative radiotherapy to the para-aortic and supraclavicular lymph nodes for pain control. After the radiotherapy, the lung lesions previously refractory to nivolumab started to decrease, probably due to an abscopal effect. Additionally, the laboratory data and Karnofsky Performance Status improved. Histological re-examination of the primary lesion revealed heterogeneity of the immunological microenvironment, which may be associated with the heterogeneity of treatment sensitivity.

摘要

本文报告了一例转移性肾细胞癌患者在接受抗程序性死亡蛋白1(PD-1)抗体治疗后出现远隔效应的病例。一名40岁女性被诊断出患有8.2厘米的肾肿瘤,无远处转移,随后进行了根治性肾切除术。病理检查显示为透明细胞肾细胞癌。术后3个月,患者出现一处肺转移。在用干扰素和三种酪氨酸激酶抑制剂治疗后,开始使用抗PD-1抗体(纳武单抗)。治疗期间,腹主动脉旁/锁骨上淋巴结及多处肺部病灶仍存在,尽管其他病灶明显缩小。随后,患者接受了针对腹主动脉旁和锁骨上淋巴结的姑息性放疗以控制疼痛。放疗后,先前对纳武单抗耐药的肺部病灶开始缩小,可能是由于远隔效应。此外,实验室数据和卡诺夫斯基功能状态评分有所改善。对原发病灶的组织学重新检查显示免疫微环境存在异质性,这可能与治疗敏感性的异质性有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05d/7027149/4adc8271b4cb/etm-19-03-1903-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验